Cargando…
Low-Dose Interleukin-2 as an Alternative Therapy for Refractory Lupus Nephritis
INTRODUCTION: Low-dose interleukin-2 (IL-2) selectively restores disturbances of regulatory T cells (Treg) and conventional T cells, resulting in the induction of remission in patients with systemic lupus erythematosus. However, to date no research has been carried out on the efficacy of low-dose IL...
Autores principales: | Zhang, Xia, Feng, Ruiling, Shao, Miao, Wang, Yifan, Sun, Xiaolin, He, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572262/ https://www.ncbi.nlm.nih.gov/pubmed/34618348 http://dx.doi.org/10.1007/s40744-021-00381-1 |
Ejemplares similares
-
Low Dose Interleukin-2 Ameliorates Sjögren’s Syndrome in a Murine Model
por: Wang, Yifan, et al.
Publicado: (2022) -
Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021) -
Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
por: Kang, Yuening, et al.
Publicado: (2020) -
Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023) -
Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)